Reaktion #1137440

ord-2dfa8a2a35c54865aedfb606eb910651

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGThe mixture was stirred for 15 minutes at rt
  2. 2
    Sonstigethe layers were separated
  3. 3
    ExtraktionThe aqueous phase was extracted with EtOAc (×2)
  4. 4
    WaschenThe combined organic extracts were washed with brine
  5. 5
    Trocknendried over Na2SO4
  6. 6
    Filtrationfiltered
  7. 7
    Einengenconcentrated
  8. 8
    SonstigeThe resulting crude product was purified by column chromatography on Biotage™ 25 g column
  9. 9
    Waschenby eluting with 50% EtOAc in DCM

Vorschrift

6-chloro-2-(((4aR,7R,8aS)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)oxy)-1-((2-(trimethylsilyl)ethoxy)methyl)-5-(4-((trimethylsilyl)ethynyl)phenyl)-1H-imidazo[4,5-b]pyridine (220 mg, 0.319 mmol) was dissolved in formic Acid (4.5 ml, 117 mmol) and sat. potassium hydrogen sulfate (0.5 ml, 0.319 mmol). The mixture was stirred at rt for 1 h, and then diluted with EtOAc. Then 3 M NaOH was added until a pH of pH 14 was reached. The mixture was stirred for 15 minutes at rt and then the layers were separated. The aqueous phase was extracted with EtOAc (×2). The combined organic extracts were washed with brine and dried over Na2SO4, filtered and concentrated. The resulting crude product was purified by column chromatography on Biotage™ 25 g column by eluting with 50% EtOAc in DCM to yield the title compound. LC-MS: m/e=400.32 (M+H)+ (Rt 1.71/4 min).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09382243B2uspto-grants-2016_07